Showing results (61-70 of 107) with videos related to
Sort By:
Pageof 11
International Journal of Biological Macromolecules|November 12, 2018
Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancerAnwei Liu, Shuxiong Zeng, Xin Lu, et al.Cancer Biomarkers : Section a of Disease Markers|October 10, 2019
Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomyAnwei Liu, Yongping Xue, Fei Liu, et al.Frontiers in Cell and Developmental Biology|February 17, 2022
Novel Non-Invasive Diagnosis of Bladder Cancer in Urine Based on Multifunctional NanoparticlesJinshan Xu, Shuxiong Zeng, Jun Li, et al.Cancer Medicine|April 11, 2023
Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cellsChen Zhang, Maoyu Wang, Yidie Ying, et al.Bioscience Reports|November 10, 2020
Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosisDafeng Xu, Yu Wang, Kailun Zhou, et al.Urologia Internationalis|August 14, 2014
Laparoscopic ureteral reimplantation underneath broad ligament tunnel for female vesicoureteral stenosis: a technical innovationChuangliang Xu, Shuxiong Zeng, Zhensheng Zhang, et al.Urology|May 3, 2014
Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumorsZhensheng Zhang, Zhi Cao, Chuanliang Xu, et al.Frontiers in Cardiovascular Medicine|April 19, 2024
Prevalence and outcomes of atrial fibrillation in patients suffering prostate cancer: a national analysis in the United StatesZhemin Pan, Xiao Xu, Xi Xu, et al.Oncotarget|February 4, 2017
Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics methodYang Zhou, Ruixiang Song, Chong Ma, et al.Oncotargets and Therapy|September 5, 2020
Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular CarcinomaDafeng Xu, Yu Wang, Kailun Zhou, et al.Pageof 11